Rs6280

From SNPedia
Jump to: navigation, search

is asnp
is mentioned by
dbSNPrs6280
nextbiors6280
hapmaprs6280
1000 genomesrs6280
hgdprs6280
ensemblrs6280
gopubmedrs6280
scholarrs6280
googlers6280
pharmgkbrs6280
gwascentralrs6280
openSNPrs6280
23andMers6280
23andMe allrs6280
SNP Nexus

SNPshotrs6280
SNPdbers6280
MSV3drs6280
GeneDRD3
Chromosome3
Orientationplus
Position113890815
ReferenceGRCh37 37.1/131
Max Magnitude0
Geno Mag Summary
(C;C) better response to olanzapine
(C;T) 0 normal
(T;T) 0 normal
? (C;C) (C;T) (T;T) 28
rs6280, also known as Ser9Gly, is a SNP in the dopamine receptor D3 DRD3 gene. The rs6280(C) allele encodes a glycine, and the (T) allele encodes a serine (in dbSNP orientation).

In a study of 88 patients being treated for schizophrenia with olanzapine, those who were rs6280(C;C) homozygotes had greater positive symptom remission (endpoint rating of minimal or none on all PANSS clinical response positive items, 39.1%), as compared with (C;T) or (T;T) genotypes (13.8%; p = 0.033). [PMID 18320559]

Ser9Gly has been implicated in executive function in some studies, but the results are conflicting.

[PMID 18348205] Associated in a family association study and pooled sample of 2,037 with nicotine dependence in Americans of European descent.


[PMID 19358223] The DRD3 rs6280 polymorphism and prevalence of tardive dyskinesia: A meta-analysis.

PharmGKBPA165111549
NameDRD3:Ser9Gly
AnnotationRisk or phenotype-associated allele: Phenotype: This meta-analysis showed no difference in clozipine response between the Ser and Gly allele. Study size: 758 Study population/ethnicity: Patients with Schizophrenia Significance metric(s): OR = 0.82, 95% confidence interval (CI): 0.65-1.04; p = 0.1 Type of association: PD
GeneDRD3
Featue
EvidencePubMed ID:20029384
Drugsclozapine
DiseasesSchizophrenia
Curation LevelCurated


[PMID 20236178] Dopamine receptor 3(DRD3) polymorphism and risk for migraine

PharmGKBPA162316713
NameDRD3: 9 Ser>Gly
AnnotationA study on 88 olanzapine-treated patients with schizophrenia found that the Gly/gly genotype was significantly associated with greater positive symptom improvement.
GeneDRD3
Featue
EvidencePubMed ID:18320559
Drugsolanzapine
DiseasesSchizophrenia
Curation LevelCurated
PharmGKBPA164807597
NameDRD3: Ser9Gly
AnnotationThis variant in the DRD3 gene was significantly associated with the therapeutic efficacy of pramipexole in Chinese patients with Parkinson's disease in a study of 30 patients.
GeneDRD3
Featue
EvidencePubMed ID:19396436
Drugspramipexole
DiseasesParkinson Disease
Curation LevelCurated
PharmGKBPA165111370
NameDRD3 Ser9Gly, DRD3 rs6280 (c.25T>C, p.S9G), DRD3:Ser9Gly
AnnotationRisk or phenotype-associated allele: C Phenotype: Carriers of the C variant (Gly) of DRD3:Ser9Gly had greater reductions in Autism Treatment Evaluation Checklist (ATEC) scores, indicating improved symptoms and response to risperidone, than TT homozygotes. Study size: 45 Study population/ethnicity: Children with Autism receiving risperidone Significance metric(s): p = 0.012 Type of association: PD
GeneDRD3
Featue
EvidencePubMed ID:19997080
Drugsrisperidone
DiseasesAutistic Disorder
Curation LevelCurated
PharmGKBPA165110867
NameDRD3: Gly9Ser
AnnotationRisk or phenotype-associated allele: C. Phenotype: A study comparing 276 patients with essential tremor and 184 normal controls confirmed the association of the Gly-9 variant in the DRD-3 gene with risk and age-at-onset of essential tremor. Study size: 276. Study population/ethnicity: French.
GeneDRD3
Featue
EvidencePubMed ID:16809426
Drugs
DiseasesEssential Tremor
Curation LevelCurated
OMIM126451
Desc
Variant0001
Relatedalso


[PMID 21491142] Dopamine receptor D3 genetic polymorphism (rs6280TC) is associated with rates of cognitive impairment in methamphetamine-dependent men with HIV: preliminary findings


[PMID 22569179] Rs1076560, a functional variant of the dopamine D2 receptor gene, confers risk of schizophrenia in Han Chinese

Personal tools
Namespaces
Variants
Actions
Navigation
Toolbox